Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma
- 21 July 2022
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 56 (5) , 869-877
Abstract
Summary: Background: Universal vaccination of newborns with hepatitis B virus (HBV) vaccine is the most important strategy to prevent chronic HBV infection and its complications of which hepatocellular carcinoma (HCC) as the deadliest.Aims: To evaluate the impact of universal HBV vaccination on the prevalence of chronic HBV infection, and the incidences of HCC and hepatic events in young adults born before and after the introduction of the universal HBV vaccination programme in 1988 in Hong KongMethods: This was a territory‐wide retrospective observational cohort study of consecutive adult subjects born in 1970–2002 with hepatitis B surface antigen (HBsAg) checked. Subjects born during the vaccination era (1988–2002) were included in the vaccinated cohort; subjects born between 1970 and 1987 were included in the unvaccinated cohort.Results: We included 695,925 subjects for HBV prevalence analysis. Chronic HBV infection dropped from 14.3% in subjects born in 1970, to 6.7% in subjects born in 1988. In total, 53,960 vaccinated and 318,290 unvaccinated subjects who had available clinical data were included for event analysis. HCC and hepatic events occurred in 44 (0.1%) and 75 (0.1%) of the vaccinated subjects and in 1305 (0.4%) and 1806 (0.6%) of the unvaccinated subjects, respectively. All incidence rates remained numerically lower in vaccinated subjects after adjustment for age, gender and antiviral treatment, but failed to reach statistical significance due to very low incidence rates.Conclusions: Universal HBV vaccination markedly reduces the prevalence of chronic HBV infection and may contribute to the decreased incidences of HCC and hepatic events.Keywords
Funding Information
- Health and Medical Research Fund (CID‐CUHK‐D)
This publication has 18 references indexed in Scilit:
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling studyThe Lancet Gastroenterology & Hepatology, 2018
- Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysisAlimentary Pharmacology & Therapeutics, 2017
- Waning Immunity Is Associated with Periodic Large Outbreaks of Mumps: A Mathematical Modeling Study of Scottish DataFrontiers in Physiology, 2017
- Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988‐2012Hepatology, 2015
- Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled TrialPLOS Medicine, 2014
- Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up StudyJNCI: Journal of the National Cancer Institute, 2009
- Occult hepatitis B virus infection in hepatitis B vaccinated children in TaiwanJournal of Hepatology, 2009
- Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinomaGut, 2004
- Changing scene in hepatitis B serology interpretationHospital Medicine, 2002
- Vaccine-induced escape mutant of hepatitis B virusThe Lancet, 1990